Cargando…
Urine proteome of autosomal dominant polycystic kidney disease patients
BACKGROUND: Autosomal dominant polycystic kidney disease (ADPKD) is responsible for 10% of cases of the end stage renal disease. Early diagnosis, especially of potential fast progressors would be of benefit for efficient planning of therapy. Urine excreted proteome has become a promising field of th...
Autores principales: | Bakun, Magda, Niemczyk, Mariusz, Domanski, Dominik, Jazwiec, Radek, Perzanowska, Anna, Niemczyk, Stanislaw, Kistowski, Michal, Fabijanska, Agnieszka, Borowiec, Agnieszka, Paczek, Leszek, Dadlez, Michal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607978/ https://www.ncbi.nlm.nih.gov/pubmed/23228063 http://dx.doi.org/10.1186/1559-0275-9-13 |
Ejemplares similares
-
Sturge–Weber syndrome coexisting with autosomal dominant polycystic kidney disease
por: Niemczyk, Mariusz, et al.
Publicado: (2012) -
Diagnostic Imaging of Autosomal Dominant Polycystic Kidney Disease
por: Gradzik, Monika, et al.
Publicado: (2016) -
A Multiplexed Cytokeratin Analysis Using Targeted Mass Spectrometry Reveals Specific Profiles in Cancer-Related Pleural Effusions()()
por: Domanski, Dominik, et al.
Publicado: (2016) -
Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis
por: Robak, Aleksandra, et al.
Publicado: (2022) -
Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
por: Nowak, Marcin M., et al.
Publicado: (2022)